Detalles de la búsqueda
1.
Single-agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differences.
Br J Haematol
; 159(2): 154-63, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22881386
2.
On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors.
Mol Cancer Ther
; 19(2): 468-478, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31619463
3.
Lenalidomide-induced tumour flare reaction in mantle cell lymphoma.
Br J Haematol
; 151(4): 410-2, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20880113
4.
Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOP.
Leuk Lymphoma
; 46(4): 549-52, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16019483
5.
Autoimmune haemolytic anaemia associated with mantle cell lymphoma.
Int J Hematol
; 91(2): 322-5, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20063131
6.
Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II study.
Leuk Lymphoma
; 50(2): 211-5, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19197729
7.
Indolent mantle-cell lymphoma: immunoglobulin variable region heavy chain sequence analysis reveals evidence of disease 10 years prior to symptomatic clinical presentation.
J Clin Oncol
; 29(15): e437-9, 2011 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21383292
8.
Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab.
Leuk Lymphoma
; 50(3): 463-5, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19197732
9.
The Simplified Mantle-Cell Lymphoma International Prognostic Index predicts overall survival but not progression-free survival in patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide +/- rituximab: results of a randomized phase II trial.
Leuk Lymphoma
; 50(10): 1709-11, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19757310
10.
Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma.
J Clin Oncol
; 27(32): e189-90; author reply e191, 2009 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19805667
11.
Cardiac involvement with mycosis fungoides: could this explain alemtuzumab toxicity?
Leuk Lymphoma
; 49(10): 2022-4, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18452071
12.
The use of "touchdown" polymerase chain reaction increases the sensitivity and specificity of t(11;14)(q13;q32) detection in patients with mantle cell lymphoma.
Br J Haematol
; 121(6): 952-3, 2003 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12786809
13.
Position paper on imatinib mesylate in chronic myeloid leukaemia.
Br J Haematol
; 119(1): 268-72, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12358935
14.
Managing cutaneous reactions to imatinib therapy.
Blood
; 100(9): 3434-5, 2002 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12412577
Resultados
1 -
14
de 14
1
Próxima >
>>